Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOB015 Topical Treatment Regimens in Distal Subungual Onychomycosis
2010-022622-32Phase 2Completed
- Sponsor
- Moberg Pharma AB
- Start
- Sep 2010
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of MOB-015 in onychomycosis (2 arms), sponsored by Moberg Pharma AB. Primary endpoint: Primary efficacy and safety comparison of two MOB015 regimens at month 12. Started Sep 2010; status: completed.
02
Drugs
MOB-015
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2010-022622-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022622-32.